Literature DB >> 30522015

Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.

Pengwei Lv1, Xinguang Qiu2, Yuanting Gu1, Xue Yang1, Xiaodong Xu1, Yunqing Yang1.   

Abstract

The long non-coding RNA (lncRNA) has recently been shown to be important regulators involved in the progression of various human cancers. Small nucleolar RNA host gene 6 (SNHG6) is a recently identified cancer-related lncRNA. However, the clinical significance and biological function of SNHG6 in breast cancer (BC) are still unclear. In the present study, we found that SNHG6 was highly expressed in BC tissues and cell lines, which was associated with poorer clinicopathologic features. Knockdown of SNHG6 inhibited BC cell proliferation, migration and invasion in vitro and in vivo using CCK-8, Edu staining, transwell assays and nude mice model. Moreover, bioinformatics analysis and luciferase reporter experiments indicated that SNHG6 serves as an endogenous sponge by directly binding to miR-26a-5p and down-regulating miR-26a-5p expression. MiR-26a-5p overexpression significantly enhanced the effect of SNHG6 knockdown on the cell behaviors in BC. Furthermore, bioinformatics analysis and luciferase reporter indicated that MAPK6 was validated as a target of miR-26a-5p. Therefore, our study may reveal a novel SNHG6/miR-26a-5p/MAPK6 pathway regulatory axis in BC pathogenesis. SNHG6 may serve as a potential prognostic and therapeutic target in the treatment of BC.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Breast cancer; MAPK6; SNHG6; miR-26a-5p

Mesh:

Substances:

Year:  2018        PMID: 30522015     DOI: 10.1016/j.biopha.2018.11.016

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGFβ/Smad signaling pathway.

Authors:  Chen Chen; Hao Li; Xintian Wang; Lei Wang; Qinghua Zeng
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 2.  The prognostic value of lncRNA SNHG6 in cancer patients.

Authors:  Haixiang Shen; Qiwang Mo; Xin Xu; Ben Liu
Journal:  Cancer Cell Int       Date:  2020-07-06       Impact factor: 5.722

3.  The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer.

Authors:  Demet Cansaran-Duman; Ümmügülsüm Tanman; Sevcan Yangın; Orhan Atakol
Journal:  Cytotechnology       Date:  2020-10-30       Impact factor: 2.058

4.  LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.

Authors:  Yufei Lv; Xiaohong Lv; Huike Yang; Xiuying Qi; Xiangchen Wang; Chao Li; Xiaochen Shang; Hongmin Guo; Jianguo Zhang; Yafang Zhang
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

5.  The Regulatory Role of circRNA_101308 in Cervical Cancer and the Prediction of Its Mechanism.

Authors:  Jun Jiao; Xinlin Jiao; Qingqing Liu; Wenjie Qu; Daoxin Ma; Youzhong Zhang; Baoxia Cui
Journal:  Cancer Manag Res       Date:  2020-06-22       Impact factor: 3.989

6.  Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray.

Authors:  Ali Mohamed Alshabi; Ibrahim Ahmed Shaikh; Chanabasayya Vastrad
Journal:  Biomolecules       Date:  2019-07-15

7.  LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop.

Authors:  Gaoliang Wu; Chao Hao; Xueliang Qi; Jianqiang Nie; Weimin Zhou; Ji Huang; Qiuming He
Journal:  Cell Death Dis       Date:  2020-05-23       Impact factor: 8.469

8.  Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.

Authors:  Shuo Zhang; Dandan Qiu; Xiaohong Xie; Yong Shen
Journal:  BMC Cancer       Date:  2020-04-22       Impact factor: 4.430

Review 9.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer.

Authors:  Zahra Sadat Razavi; Kasra Asgarpour; Maryam Mahjoubin-Tehran; Susan Rasouli; Haroon Khan; Mohammad Karim Shahrzad; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-05-15       Impact factor: 7.200

10.  Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.

Authors:  Kaiyao Hua; Xiaochong Deng; Jiashu Hu; Changle Ji; Yunhe Yu; Jiayi Li; Xuehui Wang; Lin Fang
Journal:  J Exp Clin Cancer Res       Date:  2020-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.